QoL After Complex Endovascular Aortic Repair
1 other identifier
observational
90
1 country
1
Brief Summary
The goal of this prospective observational cohort study is to compare health related quality of life in patients with abdominal aortic aneurysms treated by either standard or complex EVAR (endovascular aneurysm repair) devices. The main questions it aims to answer are:
- Compare differences between the physical scores from the preoperative to the postoperative settings between patients treated with standard EVAR vs non-standard endovascular aortic repair (F-/BEVAR)
- To compare long-term physical scores postoperatively between patients treated with standard EVAR vs non-standard endovascular aortic repair (F-/BEVAR) at one year.
- To explore at which time points (if ever) patients treated with standard-EVAR and nonstandard endovascular aortic repair (F-/BEVAR) have restored or normalized physical scores measured by SF-12, measured at 30 days, 6 months, 1 and 3 years. Participants will be asked to fill out forms pre- and postoperatively with regards to health related quality of life. The different groups for comparison will be either standard EVAR for infrarenal aortic aneurysms or complex EVAR (fenestrated or branched) for paravisceral aortic aneurysms (PVAAA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2023
CompletedFirst Submitted
Initial submission to the registry
March 7, 2023
CompletedFirst Posted
Study publicly available on registry
March 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2030
April 10, 2025
April 1, 2025
3.8 years
March 7, 2023
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Early physical component score changes after standard or complex EVAR procedure.
To compare the difference between the physical scores from the preoperative to the postoperative settings between patients treated with standard EVAR vs non-standard endovascular aortic repair (F-/BEVAR) at 30 days.
2026
Secondary Outcomes (2)
Late physical component score changes after standard or complex EVAR procedure.
2026
When does physical component scores return to normal after standard or complex EVAR procedures?
2028
Study Arms (2)
Standard EVAR
Infrarenal abdominal aortic aneurysms treated with standard EVAR off-the-shelf devices.
Complex EVAR
Paravisceral aortic aneurysms treated with fenestrated or branched EVAR devices.
Interventions
Standard EVAR treatment with Medtronic Endurant IIs (Medtronic, Inc. - Minneapolis, Minnesota), Gore Excluder AAA (W. L. Gore \& Associates, Inc. - Newark, Delaware), Gore Excluder Conformable AAA (W. L. Gore \& Associates, Inc. - Newark, Delaware), Cook Zenith Flex (Cook Medical, Inc. - Bloomington, Indiana).
Complex EVAR treatment with custom made devices (CMD's) from Cook Medical (Cook Medical, Inc. - Bloomington, Indiana) including fenestrated or branched devices or off-the-shelf T-branch device (Cook Medical, Inc. - Bloomington, Indiana).
Eligibility Criteria
All patients with infrarenal or paravisceral aortic aneurysms planned for treatment with EVAR or F-/BEVAR will be invited to participate in the study at the time of consent of the proposed treatment
You may qualify if:
- Men and women.
- Any age (≥18 years)
- Planned (elective) endovascular treatment by EVAR, FEVAR or BEVAR.
- Patients previously treated by EVAR which are planned for an adjunct fenestrated cuff will not be included in the basic analysis, but included and analysed separately.
You may not qualify if:
- Inability to understand and/or respond to the study questionnaires that are in Swedish.
- Inability to provide an informed consent for participation in the study, orally or in writing (This may be due to linguistic or cognitive limitation).
- Participation in other ongoing studies concerning quality of life.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karolinska University Hospital
Stockholm, 17176, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adjunct professor
Study Record Dates
First Submitted
March 7, 2023
First Posted
March 20, 2023
Study Start
February 28, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
January 1, 2030
Last Updated
April 10, 2025
Record last verified: 2025-04